Hobart Private Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Buy
1,499
+269
+22% +$62.7K 0.07% 109
2026
Q1
$301K Buy
1,230
+132
+12% +$30.7K 0.06% 106
2025
Q4
$227K Buy
+1,098
New +$217K 0.04% 122
2021
Q1
Sell
-1,803
Closed -$284K 151
2020
Q4
$284K Sell
1,803
-52
-3% -$7.67K 0.12% 123
2020
Q3
$276K Sell
1,855
-165
-8% -$24.4K 0.14% 123
2020
Q2
$284K Buy
2,020
+268
+15% +$39.1K 0.16% 132
2020
Q1
$230K Hold
1,752
0.16% 139
2019
Q4
$256K Buy
1,752
+100
+6% +$13.6K 0.16% 140
2019
Q3
$214K Hold
1,652
0.15% 140
2019
Q2
$230K Hold
1,652
0.16% 129
2019
Q1
$231K Sell
1,652
-2,083
-56% -$279K 0.18% 144
2018
Q4
$482K Buy
3,735
+305
+9% +$42.5K 0.41% 71
2018
Q3
$474K Buy
3,430
+965
+39% +$128K 0.36% 80
2018
Q2
$299K Buy
2,465
+404
+20% +$50.4K 0.24% 100
2018
Q1
$264K Sell
2,061
-239
-10% -$32.3K 0.23% 97
2017
Q4
$321K Buy
+2,300
New +$320K 0.29% 91

Other funds holding JNJ

Hobart Private Capital's JNJ Position: Q2 2026 in Review

Hobart Private Capital increased its Johnson & Johnson (JNJ) stake by 22% in Q2 2026, buying an estimated $62.7K and bringing the position to 1,499 shares worth $381K. The position accounts for 0.07% of the portfolio, ranked #109.

Hobart Private Capital first reported a position in JNJ in Q4 2017 and has held it in 16 quarters since. The position peaked at $482K in Q4 2018. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Hobart Private Capital held 1,499 shares of Johnson & Johnson worth $381K as of Q2 2026.
  • Hobart Private Capital bought 269 Johnson & Johnson shares in Q2 2026, an estimated $62.7K.
  • Johnson & Johnson made up 0.07% of Hobart Private Capital's portfolio in Q2 2026, its #109 holding.
  • Hobart Private Capital first reported a position in Johnson & Johnson in Q4 2017 and has held it in 16 quarters since.
  • Hobart Private Capital's Johnson & Johnson position peaked at $482K in Q4 2018.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Hobart Private Capital's 13F filing for Q2 2026, filed 6 Jul 2026.